Peripheral Artery Disease

Peripheral artery disease (PAD) involves atherosclerosis mainly in the extremities, especially in the legs and feet that lead to ischemia. Untreated, PAD can progress to critical limb ischemia (CLI), also called chronic limb-threatening ischemia (CLTI), which will lead to foot or leg amputation. The mortality rate for these CLI amputees is 70% within three years. There is currently an epidemic of PAD and CLI in the U.S. The majority of patients are defined by health disparities concentrated in the Black, Latino, Native American populations in both rural and low-income urban areas. A large number of PAD patients have other comorbities, with diabetes being one a primary issue.

money business cash flow dollar

Cordis finalizes deal to acquire MedAlliance for up to $1.1B

The total value of the acquisition, first announced in 2022, is dependent on various regulatory and commercial milestones.

Medtronic has received FDA approval for its IN.PACT 018 Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter

FDA says treating PAD with paclitaxel-coated devices does not increase mortality risk

After warning healthcare providers about a heightened risk of mortality back in 2019, the FDA has now updated its stance on the use of these devices. 

The Surmodics Pounce Thrombectomy System

FDA clears new ‘grab-and-go’ interventional device for below-the-knee blood clot removal

The new device was designed to remove thrombi and emboli from peripheral arteries ranging from 2 to 4 mm. 

Thumbnail

Marijuana use linked to much higher risk of peripheral artery disease

New research presented at SCAI Scientific Sessions 2023 suggests that marijuana users should understand the early warning signs of PAD, including feelings of pain and coldness in the leg. 

Thumbnail

Why women with peripheral artery disease are underdiagnosed, have worse outcomes

Using the World Health Organization’s model for analyzing gender-related healthcare needs, the authors of a new analysis aimed to explore disparities in PAD outcomes.

Thumbnail

Cardiologists warn Biden administration that new policies could put PAD patients at risk

SCAI and the Association of Black Cardiologists have joined forces to share a simple message: PAD patients would be negatively impacted by new CMS proposals. 

Sahil Parikh explains the tread of cardiology departments treating critical limb ischemia (CLI) at AHA 2022.

Interventional cardiology's role in treating CLI continues to evolve

Sahil Parikh, MD, talked to Cardiovascular Business about growing trends related to the treatment of critical lower limb ischemia. "We are getting better and better at saving their limbs, but we are not better at saving their lives," he said. 

Sahil A. Parikh, MD, Director of Endovascular Services at Columbia University Irving Medical Center and Associate Professor of Medicine at the Columbia University College of Physicians and Surgeons, explained the growing trend or interventional cardiologists treating PAD and CLI. He shares what he thinks is important for cardiology departments to know before expanding expanding their programs in this space.

What do interventional cardiologists need to treat PAD and CLI?

Sahil Parikh, MD, director of endovascular services at Columbia University Irving Medical Center, said treating these patients can be quite challenging. 

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.